Sylvie Courtois

Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management

Mathieu Anheim, Marie‐Céline Fleury, B. Monga et al. · Neurogenetics · 2009 · 185 citations

Life Sciences, Genetics, Neurology +15

Switching From Natalizumab to Fingolimod in Multiple Sclerosis

Mikaël Cohen, Élisabeth Maillart, Ayman Tourbah et al. · JAMA Neurology · 2014 · 140 citations

Medicine, Neurology, Pharmacotherapy +16

Impact of the COVID‐19 outbreak on acute stroke pathways – insights from the Alsace region in France

Raoul Pop, Véronique Quenardelle, Anca Hasiu et al. · European Journal of Neurology · 2020 · 93 citations · Full text

Medicine, Infectious Diseases, Cerebrovascular Surgery +14

Delayed‐onset Friedreich's ataxia revisited

Claire Lecocq, Perrine Charles, Jean‐Philippe Azulay et al. · Movement Disorders · 2015 · 71 citations

Medicine, Neurology, Neuroscience +13

Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study

Kévin Bigaut, Laurent Kremer, Thibaut Fabacher et al. · Journal of Neurology · 2022 · 25 citations · Full text

Medicine, Neurology, Pharmacotherapy +11